Adage Capital Partners Portfolio holdings
AUM
$59.3B
1-Year Return
26.26%
This Quarter Return
+11%
1 Year Return
+26.26%
3 Year Return
+130.73%
5 Year Return
+248.99%
10 Year Return
+658.76%
AUM
$40.7B
AUM Growth
-$4.56M
(-0.01%)
Cap. Flow
-$3.49B
Cap. Flow
% of AUM
-8.57%
Top 10 Holdings %
Top 10 Hldgs %
19.9%
Holding
801
New
88
Increased
169
Reduced
396
Closed
90
Top Buys
| 1 |
RTX Corp
RTX
|
$171M |
| 2 |
Bristol-Myers Squibb
BMY
|
$142M |
| 3 |
Costco
COST
|
$132M |
| 4 |
3M
MMM
|
$118M |
| 5 |
Johnson Controls International
JCI
|
$117M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$1.48B |
| 2 |
Apple
AAPL
|
$155M |
| 3 |
Under Armour
UAA
|
$130M |
| 4 |
CenterPoint Energy
CNP
|
$123M |
| 5 |
Marathon Petroleum
MPC
|
$119M |
Sector Composition
| 1 | Technology | 17.43% |
| 2 | Healthcare | 16.85% |
| 3 | Financials | 12.9% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Industrials | 10.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Fortive
FTV
$16.2B
| $26.1M | 0.06% |
+408,293
| New | +$26.1M |
|
327
Jack Henry & Associates
JKHY
$11.8B
| $26M | 0.06% |
178,810
-9,788
| -5% | -$1.43M |
|
328
ResMed
RMD
$40.6B
| $26M | 0.06% |
167,590
-7,075
| -4% | -$1.1M |
|
|
NVRO
329
DELISTED
NEVRO CORP.
NVRO
| $25.9M | 0.06% |
220,000
-30,000
| -12% | -$3.53M |
|
330
Cintas
CTAS
$82.4B
| $25.8M | 0.06% |
384,000
-27,200
| -7% | -$1.83M |
|
331
Idexx Laboratories
IDXX
$51.4B
| $25.8M | 0.06% |
98,919
-5,700
| -5% | -$1.49M |
|
332
Weyerhaeuser
WY
$18.9B
| $25.7M | 0.06% |
850,300
-541,200
| -39% | -$16.3M |
|
333
Peloton Interactive
PTON
$3.27B
| $25.7M | 0.06% |
903,500
-1,425,000
| -61% | -$40.5M |
|
334
Dollar Tree
DLTR
$20.6B
| $25.7M | 0.06% |
272,791
-225,207
| -45% | -$21.2M |
|
|
ANSS
335
DELISTED
Ansys
ANSS
| $25.5M | 0.06% |
99,200
-2,200
| -2% | -$566K |
|
|
CXO
336
DELISTED
CONCHO RESOURCES INC.
CXO
| $25.2M | 0.06% |
288,200
+48,900
| +20% | +$4.28M |
|
337
Xenon Pharmaceuticals
XENE
$3.02B
| $25.2M | 0.06% |
1,925,000
+625,000
| +48% | +$8.19M |
|
338
MSCI
MSCI
$42.9B
| $25.1M | 0.06% |
97,300
-4,700
| -5% | -$1.21M |
|
|
BLUE
339
DELISTED
bluebird bio
BLUE
| $25M | 0.06% |
+22,002
| New | +$25M |
|
340
Hershey
HSY
$37.6B
| $25M | 0.06% |
170,085
-8,200
| -5% | -$1.21M |
|
341
Ball Corp
BALL
$13.9B
| $25M | 0.06% |
386,097
+35,400
| +10% | +$2.29M |
|
342
Ventas
VTR
$30.9B
| $24.6M | 0.06% |
426,700
-20,600
| -5% | -$1.19M |
|
343
SS&C Technologies
SSNC
$21.7B
| $24.6M | 0.06% |
400,000
+57,584
| +17% | +$3.54M |
|
344
CDW
CDW
$22.2B
| $24.4M | 0.06% |
170,500
-117,900
| -41% | -$16.8M |
|
345
Champion Homes, Inc.
SKY
$4.43B
| $24M | 0.06% |
758,572
+158,572
| +26% | +$5.03M |
|
346
McCormick & Company Non-Voting
MKC
$19B
| $24M | 0.06% |
282,830
-13,600
| -5% | -$1.15M |
|
347
Equity Residential
EQR
$25.5B
| $23.9M | 0.06% |
295,795
-42,903
| -13% | -$3.47M |
|
348
AerCap
AER
$22B
| $23.9M | 0.06% |
388,424
+170,616
| +78% | +$10.5M |
|
349
CBRE Group
CBRE
$48.9B
| $23.6M | 0.06% |
385,100
-18,500
| -5% | -$1.13M |
|
350
OneMain Financial
OMF
$7.31B
| $23.6M | 0.06% |
559,458
-136,342
| -20% | -$5.75M |
|